Health · Full coverage
New Weight Loss Pills Launch in Israel Amidst Affordability Concerns
How 4 Israeli newsrooms (in Russian, Hebrew) covered this story — translated into English and compared side by side.
Center 1Unrated 3
By Вести - Ynet
First reported by Globes · 1 day ago
What happened
Eli Lilly's new oral weight loss medication, Foundayo, will be available in Israeli pharmacies starting September 15. While offering convenience over injections, its high cost, not covered by insurance, is a major concern for accessibility, despite its proven effectiveness in clinical trials.
- 01New Foundayo weight loss pills launch in Israel on September 15.
- 02The oral medication offers convenience over injectable GLP-1 treatments.
- 03High cost and lack of insurance coverage pose accessibility challenges.
- 04Clinical trials show significant weight loss and health improvements.
- 05Foundayo is less potent than some leading injectable weight loss drugs.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 4 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
New Daily Pill for Obesity Treatment Expected in Israel Post-Rosh Hashanah1 day agoIsraeli Weight-Loss Pill Developer Appoints New CEO to Revive Struggling CompanyAug 12, 2026Weight Loss Injection Reduces Appetite and Transforms Israel's Food IndustryAug 3, 2026Eli Lilly’s New Weight Loss Drug Sparks Controversy Before Market LaunchJun 30, 2026Israeli Health Ministry Warns Against Dangerous Weight Loss Product Containing Banned DrugAug 4, 2026FDA Approves New Daily Pill for Lowering Bad Cholesterol with Israeli Clinical Trial ParticipationJul 17, 2026